A Prospective, Multicenter, Single Arm, Post-Approval Study of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females

Trial Profile

A Prospective, Multicenter, Single Arm, Post-Approval Study of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Aug 2018

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Peripheral arterial disorders
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms CONFIRM
  • Sponsors C.R. Bard
  • Most Recent Events

    • 24 Apr 2018 Status changed from not yet recruiting to recruiting.
    • 27 Feb 2018 Planned number of patients changed from 160 to 165.
    • 27 Feb 2018 Planned End Date changed from 1 Jan 2020 to 1 Dec 2022.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top